Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FTRE is expected to report earnings to rise 152.63% to 47 cents per share on November 17
Q3'25
Est.
$0.48
Q2'25
Beat
by $0.11
Q1'25
Missed
by $0.39
Q4'24
Missed
by $0.24
Q3'24
Missed
by $0.09
The last earnings report on August 06 showed earnings per share of 18 cents, beating the estimate of 7 cents. With 1.47M shares outstanding, the current market capitalization sits at 819.92M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. FTRE showed earnings on August 06, 2025. You can read more about the earnings report here.